1 year return (CAGR)
-17.77%
Entrada Therapeutics Inc Exchange (NASDAQ, USD)
TRDA
6.50
-9.18 (-57.27%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-16.98%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
265.92M
Price/Sales
10.46
Ent value
246.77M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 6.70 |
| Daily high | 7.89 |
| Daily low | 5.73 |
| Daily Volume | 4.11M |
| All-time high | 35.00 |
| 1y analyst estimate | 19.00 |
| Beta | -0.25 |
| EPS (TTM) | -3.93 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| TRDA | S&P500 | |
| Current price drop from All-time high | -81.43% | -1.29% |
| Highest price drop | -85.66% | -56.47% |
| Date of highest drop | 11 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -62.28% | -10.68% |
| Avg time to new high | 142 days | 12 days |
| Max time to new high | 1121 days | 1805 days |
News
